0001214659-23-013090.txt : 20231003
0001214659-23-013090.hdr.sgml : 20231003
20231003170246
ACCESSION NUMBER: 0001214659-23-013090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230905
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAZIMI A J
CENTRAL INDEX KEY: 0001075050
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 231305105
MAIL ADDRESS:
STREET 1: 1207 17TH AVENUE SUITE 103
CITY: NASHVILLE
STATE: TN
ZIP: 37212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
marketforms-62743.xml
PRIMARY DOCUMENT
X0508
4
2023-09-05
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001075050
KAZIMI A J
1600 WEST END AVE.
SUITE 1300
NASHVILLE
TN
37203
true
true
true
false
Chairman and CEO
1
Common Stock
2023-09-05
5
L
false
E
65
1.68
A
5716965
D
Common Stock
2023-09-06
5
L
false
E
65
1.65
A
5717030
D
Common Stock
2023-09-07
5
L
false
E
65
1.68
A
5717095
D
Common Stock
2023-09-08
5
L
false
E
65
1.68
A
5717160
D
Common Stock
2023-09-11
5
L
false
E
65
1.71
A
5717225
D
Common Stock
2023-09-12
5
L
false
E
65
1.76
A
5717290
D
Common Stock
2023-09-13
5
L
false
E
65
1.83
A
5717355
D
Common Stock
2023-09-14
5
L
false
E
65
1.84
A
5717420
D
Common Stock
2023-09-15
5
L
false
E
23
1.82
A
5717443
D
Common Stock
2023-09-18
5
L
false
E
55
2.03
A
5717498
D
Common Stock
2023-09-19
5
L
false
E
55
2.12
A
5717553
D
Common Stock
2023-09-20
5
L
false
E
55
2.14
A
5717608
D
Common Stock
2023-09-21
5
L
false
E
55
2.28
A
5717663
D
Common Stock
2023-09-22
5
L
false
E
55
2.29
A
5717718
D
Common Stock
2023-09-25
5
L
false
E
55
2.24
A
5717773
D
Common Stock
2023-09-26
5
L
false
E
55
2.07
A
5717828
D
Common Stock
2023-09-27
5
L
false
E
55
1.98
A
5717883
D
Common Stock
2023-09-28
5
L
false
E
55
1.96
A
5717938
D
Common Stock
2023-09-29
5
L
false
E
55
1.90
A
5717993
D
The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
2023-10-03